Moyamoya Disease Involving Anterior and Posterior Circulation in Pediatric Ischemic Stroke Rare Case Report
Abstract
Highlight:
- Moyamoya disease is one of the causes of stroke in children
- Moyamoya disease typically involves anterior circulation
- Posterior circulation may also be involved in certain cases of Moyamoya disease
ABSTRACT
Introduction: Ischemic stroke is frequently observed in adults but may also occur in children. Moyamoya disease (MMD) is one of the causes of ischemic stroke in children. MMD is a progressive steno-occlusive large-vessel cerebral arteriopathy. MMD was initially defined as changes in the carotid artery with an abnormal vascular network, however, the changes were also noted in posterior circulation. Case: We reported the case of a 13-year-old male with right-sided weakness persisting for over 3 years. Magnetic resonance imaging revealed cortical infarction in the left parietal lobe. Digital subtraction angiography (DSA) confirmed moyamoya disease by revealing total occlusion of the bilateral terminal internal carotid artery and bilateral posterior cerebral artery, accompanied by a puff of smoke appearance. We treated this patient with antiplatelet therapy for secondary stroke prevention. Conclusion: MMD is one of the conditions that can cause ischemic stroke in children. The posterior circulation is another possible site of MMD manifestation, but it is mostly found in cerebral anterior circulation.
Full text article
References
1. Rawanduzy CA, Earl E, Mayer G, Lucke-Wold B. Pediatric stroke: a review of common etiologies and management strategies. Biomedicines. 2022;11(1):2. DOI: 10.3390/biomedicines11010002
2. Zhang H, Zheng L, Feng L. Epidemiology, diagnosis and treatment of moyamoya disease. Exp Ther Med. 2019;17(3):1977-84. DOI: 10.3892/etm.2019.7198
3. Demartini Jr Z, Teixeira BC, Koppe GL, Gatto LA, Roman A, Munhoz RP. Moyamoya disease and syndrome: a review. Radiologia brasileira. 2022;55:31-7. DOI:10.1590/0100-3984.2021.0010
4. Zhang Q, Zhang D, Wang R, Liu Y, Zhang Y, Wang S, et al. Clinical and Angiographic Features of Patients with Moyamoya Disease and the p.R4810K Heterozygous Variant. World Neurosurg. 2016;90:530-538. DOI: 10.1016/j.wneu.2015.12.093
5. Lee JY, Kim SK, Phi JH, Wang KC. Posterior cerebral artery insufficiency in pediatric moyamoya disease. Journal of Korean Neurosurgical Society. 2015;57(6):436-9. DOI: 10.3340/jkns.2015.57.6.436
6. Irhadi MuhF, Rachman ME, Kaelan C. Literature Review : Relationship Between Moyamoya Disease And Cerebral Iscemic Incidents. Jurnal Eduehelath. 2024;15:2024. Available at: https://ejournal.seaninstitute.or.id/index.php/healt/article/view/5405
7. Kuroda S, Fujimura M, Takahashi J, Kataoka H, Ogasawara K, Iwama T, et al. Diagnostic Criteria for Moyamoya Disease-2021 Revised Version. Neurol Med Chir (Tokyo). 2022;62(7):307–12. DOI: 10.2176/jns-nmc.2022-0072
8. Goswami M, Pandian R, Sharma S. Moyamoya disease—“A puff of smoke”: A rare pediatric case report. Int J Clin Pediatr Dent. 2020;13(5):566–8. DOI: 10.5005/jp-journals-10005-1790
9. Bao XY, Tong HY, Wang QN, Wang XP, Gao G, Zhang Q, et al. A long-term study of posterior circulation changes after revascularization in patients with moyamoya disease. J Neurosurg. 2023;139(5):1281–6. DOI: 10.3171/2023.2.jns222649
10. Lee JY, Kim SK, Cheon JE, Choi JW, Phi JH, Kim IO, et al. Posterior cerebral artery involvement in moyamoya disease: Initial infarction and angle between PCA and basilar artery. Child’s Nervous System. 2013;29(12):2263–9. DOI: 10.1007/s00381-013-2123-7
11. Hori S, Kashiwazaki D, Yamamoto S, Acker G, Czabanka M, Akioka N, et al. Impact of Interethnic Difference of Collateral Angioarchitectures on Prevalence of Hemorrhagic Stroke in Moyamoya Disease. Clin Neurosurg. 2019;85(1):134–45. DOI: 10.1093/neuros/nyy236
12. Dlamini N, Muthusami P, Amlie-Lefond C. Childhood Moyamoya: Looking Back to the Future. Vol. 91, Pediatric Neurology. Elsevier Inc.; 2019. p. 11–9. DOI: 10.1016/j.pediatrneurol.2018.10.006
13. Wouters A, Smets I, Van den Noortgate W, Steinberg GK, Lemmens R. Cerebrovascular events after surgery versus conservative therapy for moyamoya disease: a meta-analysis. Vol. 119, Acta Neurologica Belgica. Springer-Verlag Italia s.r.l.; 2019. p. 305–13. DOI: 10.1007/s13760-019-01165-9
14. Hayashi T, Kimiwada T, Karibe H, Shirane R, Sasaki T, Metoki H, et al. Preoperative Risks of Cerebral Infarction in Pediatric Moyamoya Disease. Stroke. 2021;52(7):2302–10. DOI: 10.1161/strokeaha.120.032699
15. Lim WK, Ong LC, Tan KA, Li L, Teh CM, Heng HS, et al. Clinical features and outcomes of paediatric moyamoya vasculopathy in Malaysia. Neurol Asia. 2022;27(3):617–27. DOI: 10.54029/2022pvt
Authors
Copyright (c) 2025 Subandi Subandi, Lothar Matheus Manson Vanende Silalahi

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.